Congratulations to all 2024 ASCO Conquer Cancer, the ASCO Foundation awardees! Especially to Mayo Clinic’s Saurabh Zanwar, Dhauna Karam MD and Michael Storandt! Mayo Clinic Hematology-Oncology Fellowship Mayo Clinic Comprehensive Cancer Center - well done guys!

Last meeting of the now sunsetting ASCO Health Equity and Outcomes Committee. It’s been an excellent experience serving on this committee Looking forward to my tenure over the next two years on the newly formed ASCO Equity, Diversity and Inclusion Committee.

Congratulations Hope Rugo !!! This is VERY well deserved! Thank you for all your contributions to breast oncology!

OncoAlert #bcsm

This came in the mail today. Book chapter with the giants in the field 😀😇

Also available at:
m.perspectivesinmedicine.cshlp.org/content/early/…

📣What is the role of immune activation on the prognosis of early #TNBC if chemo is not given? We evaluated ~ 2,000 pts w eTNBC from 13 institutions around the globe to answer this. See our results published today in JAMA

jamanetwork.com/journals/jama/…

“Unlock the future of breast cancer management with Sid Yadav MD, FACP , FACP, as he discusses personalized strategies for mutation carriers.”

Join us on 🗓️March 23 at 4:00 PM EST for this exclusive Medical Spotlight MedNewsWeek on #YouTube Live!

🔥🔊Our next one is on JCO Global Oncology
💥🩺 Refrain from treating with the options listed in a molecular diagnostic report.
🤝 Molecular Tumor Board/ specialists a must ✅
bhawna sirohi Aju Mathew
#precisiononcology #cancergenomics #cancertreatment #oncology

Dr. Iván R. González IASLC Dave Grawoig, Ph.D. Andrew Beggs Dr. Allyson Ocean Vamsi Velcheti, MD MBA Reiner  Sergey Minaev Martín Lázaro Yan Leyfman, MD Sid Yadav MD, FACP ICAPEM Nina Maouelainin, DO, FCCP, MBA Romualdo Barroso, MD PhD Shiv Smith 💙 PRRMOJ - Openventio Publishers Wungki Park, MD MS Piotr Okupski #CellTherapy another piece of the puzzle for curing metastatic tumors. Between IO, next generation / even better ADCs and newest cancer vacc, amazingly it’s not a ‘naive pipe dream’ any longer to cure metastatic solid tumors either, if done personalized: beautiful brave new world

Final results from #ASCENT out in Journal of Clinical Oncology. SG nearly doubled OS vs. chemo in pts with pretreated mTNBC. Some association noted bw Trop2 IHC expression and outcomes with SG, although a numerical benefit vs. chemo was seen in all Trop2 groups. Sara Tolaney ascopubs.org/doi/10.1200/JC…

#CellTherapy for #SolidTumors by Dr. Prasad S Adusumilli
IASLC #WCLC20 #Day2

Dave Grawoig, Ph.D. Andrew Beggs Dr. Allyson Ocean Vamsi Velcheti, MD MBA Reiner  Sergey Minaev Martín Lázaro Nicole Kuderer, MD, MS, FASCO 🌎🇺🇸🇪🇺🇺🇦🌏

The Binaytara Foundation 's Best of ASH & SABCS in Minneapolis, MN is off to a fantastic start! Led by Drs. Shaji Kumar Sid Yadav MD, FACP Roberto Leon-Ferre of Mayo Clinic, #Binaytara #hematology #oncology #MayoClinic

Missing the molecular mdt these few wks - our next one on 15 th mar! Decision making is complex - each NGS report needs to be discussed in a mol mdt! Can’t thank our experts enough for helping us make the right decisions for each pt. Dr Riyaz Shah Sid Yadav MD, FACP dr nitesh rohatgi Anu R I

It’s now the era of ADC’s - Antibody Drug Conjugates in oncology 👉🏼The target atlas for antibody-drug conjugates across solid cancers published in Cancer Gene Therapy provides a nice overview. nature.com/articles/s4141…

A good mentor makes you feel the way I felt leaving the office of my old dean, 40 years ago, crossing the street from the medical school back to the hospital: more grounded than before we’d spoken, and also lighter than air. What Is a Mentor? | NEJM nejm.org/doi/full/10.10…

In academia there are probably more failures than there are successes. Here’s one: Our clinical trial proposal got rejected at the NRG meeting today. However, we received quite a few constructive comments. We will learn from our failures and keep on trying until we succeed. 🙏🙏

One of the most critical features of novel ADCs is their emerging intracranial activity. Few treatments in oncology allow to achieve >50% intracranial response rates, with durable (PFS 15 months!!) efficacy. Interesting meta-analysis - follow ESMO Open for more! 👇

Useful recommendations out in npj Journals Breast on the management of hyperglycemia and rash induced by alpelisib 🥵🍬📈
➡️Prophylactic metformin for HbA1c 5.7%-6.4%
➡️Antihistamines for profilaxis, antihistamines+topical steroids as1️⃣treatment
OncoAlert
nature.com/articles/s4152…

Do you have thoughts on ADC sequencing in breast cancer?

Join us tomorrow #TumorBoardTuesday for more on this topic.

Rachel Occhiogrosso Abelman, MD Aditya Bardia, MD Heather McArthur, MD, MPH Stephanie Graff, MD, FACP, FASCO Lisa Carey, MD, ScM, FASCO Dr Sarah Sammons Joannie M. Ivory, MD, MSPH, MHS
Kevin Kalinsky, MD, MS Shipra Gandhi Arya Roy Paola Zagami, MD Paolo Tarantino

⭐️Today is #WorldCancerDay ! The global cancer incidence is on the rise, and the global cancer burden is expected to reach 28.4 million cases in 2040, a 47% rise from 2020.
👉🏼Globalizing precision oncology should be a major priority for cancer care in the upcoming decades. It is…

On #WorldCancerDay2024 I’m grateful to patients, family members, physicians, researchers, policymakers & many other individuals who have contributed to advancing the science of cancer prevention & treatment. We still have a long way to go but together we will prevent/cure cancer.